Tag
An HIV vaccine developed by La Jolla Institute for Immunology and Scripps Research has shown unprecedented success in generating broadly neutralizing antibodies in primates, with human trials now underway.
Researchers at the University of Cambridge have developed the first entirely AI-designed vaccine, which targets entire virus families and has successfully completed a Phase I human trial showing safety and broad immune response.
Moderna received $50 million from CEPI to develop an mRNA Ebola vaccine targeting the Bundibugyo strain, amid a severe outbreak in DRC with over 1,000 cases and 241 deaths.